Does DARBEPOETIN ALFA Cause Gait inability? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Gait inability have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.1% of all adverse event reports for DARBEPOETIN ALFA.
25
Reports of Gait inability with DARBEPOETIN ALFA
0.1%
of all DARBEPOETIN ALFA reports
7
Deaths
21
Hospitalizations
How Dangerous Is Gait inability From DARBEPOETIN ALFA?
Of the 25 reports, 7 (28.0%) resulted in death, 21 (84.0%) required hospitalization, and 4 (16.0%) were considered life-threatening.
Is Gait inability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Gait inability?
ADALIMUMAB (3,844)
ETANERCEPT (2,710)
METHOTREXATE (2,559)
TOFACITINIB (2,227)
SECUKINUMAB (2,216)
TOCILIZUMAB (2,139)
LEFLUNOMIDE (2,065)
RITUXIMAB (2,028)
ABATACEPT (2,019)
HYDROXYCHLOROQUINE (1,881)
Which DARBEPOETIN ALFA Alternatives Have Lower Gait inability Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE